These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18302449)

  • 1. Improving the detection of subtle I(Kr)-inhibition: assessing electrocardiographic abnormalities of repolarization induced by moxifloxacin.
    Couderc JP; McNitt S; Hyrien O; Vaglio M; Xia X; Polonsky S; Moss AJ; Zareba W
    Drug Saf; 2008; 31(3):249-60. PubMed ID: 18302449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-wave morphology abnormalities in benign, potent, and arrhythmogenic I(kr) inhibition.
    Couderc JP; Xia X; Peterson DR; McNitt S; Zhao H; Polonsky S; Moss AJ; Zareba W
    Heart Rhythm; 2011 Jul; 8(7):1036-43. PubMed ID: 21315844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre study.
    Matz J; Graff C; Vainio PJ; Kallio A; Højer AM; Struijk JJ; Kanters JK; Andersen MP; Toft E
    Clin Drug Investig; 2011 Nov; 31(11):799-811. PubMed ID: 21967071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic method for identifying drug-induced repolarization abnormalities associated with a reduction of the rapidly activating delayed rectifier potassium current.
    Couderc JP; Vaglio M; Xia X; McNitt S; Hyrien O
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():4010-5. PubMed ID: 17946595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bilastine on T-wave morphology and the QTc interval: a randomized, double-blind, placebo-controlled, thorough QTc study.
    Graff C; Struijk JJ; Kanters JK; Andersen MP; Toft E; Tyl B
    Clin Drug Investig; 2012 May; 32(5):339-51. PubMed ID: 22393898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of parameters highlighting drug induced small changes of the T-wave's morphology for drug safety studies.
    Baas T; Gräfe K; Khawaja A; Dössel O
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():3796-9. PubMed ID: 22255166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.
    de Kam PJ; van Kuijk J; Smeets J; Thomsen T; Peeters P
    Int J Clin Pharmacol Ther; 2012 Aug; 50(8):595-604. PubMed ID: 22735462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying drug-induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: a study of sotalol effects on T-wave morphology.
    Graff C; Andersen MP; Xue JQ; Hardahl TB; Kanters JK; Toft E; Christiansen M; Jensen HK; Struijk JJ
    Drug Saf; 2009; 32(7):599-611. PubMed ID: 19530746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of QT prolongation using a novel electrocardiographic analysis algorithm applying intelligent automation: prospective blinded evaluation using the Cardiac Safety Research Consortium electrocardiographic database.
    Green CL; Kligfield P; George S; Gussak I; Vajdic B; Sager P; Krucoff MW
    Am Heart J; 2012 Mar; 163(3):365-71. PubMed ID: 22424006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the effect of sotalol on the repolarization intervals in healthy young individuals.
    Couderc JP; Zhou M; Sarapa N; Zareba W
    J Electrocardiol; 2008; 41(6):595-602. PubMed ID: 18801493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT prolongation and proarrhythmia by moxifloxacin: concordance of preclinical models in relation to clinical outcome.
    Chen X; Cass JD; Bradley JA; Dahm CM; Sun Z; Kadyszewski E; Engwall MJ; Zhou J
    Br J Pharmacol; 2005 Nov; 146(6):792-9. PubMed ID: 16158069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.
    Holzgrefe HH; Cavero I; Buchanan LV; Gill MW; Durham SK
    J Pharmacol Toxicol Methods; 2007; 55(3):227-37. PubMed ID: 17097307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of moxifloxacin on QTc and implications for the design of thorough QT studies.
    Bloomfield DM; Kost JT; Ghosh K; Hreniuk D; Hickey LA; Guitierrez MJ; Gottesdiener K; Wagner JA
    Clin Pharmacol Ther; 2008 Oct; 84(4):475-80. PubMed ID: 19238652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for I(Ks).
    Ducroq J; Moha ou Maati H; Guilbot S; Dilly S; Laemmel E; Pons-Himbert C; Faivre JF; Bois P; Stücker O; Le Grand M
    Br J Pharmacol; 2010 Jan; 159(1):93-101. PubMed ID: 19703166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly automated QT measurement techniques in 7 thorough QT studies implemented under ICH E14 guidelines.
    Couderc JP; Garnett C; Li M; Handzel R; McNitt S; Xia X; Polonsky S; Zareba W
    Ann Noninvasive Electrocardiol; 2011 Jan; 16(1):13-24. PubMed ID: 21251129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of common marmosets to detect drug-induced QT interval prolongation: moxifloxacin case study.
    Komatsu R; Honda M; Holzgrefe HH; Kubo J; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
    J Pharmacol Toxicol Methods; 2010; 61(3):271-6. PubMed ID: 20097298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A statistical assessment of QT data following placebo and moxifloxacin dosing in thorough QT studies.
    Stylianou A; Roger J; Stephens K
    J Biopharm Stat; 2008; 18(3):502-16. PubMed ID: 18470759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxifloxacin-induced QT prolongation and torsades: an uncommon effect of a common drug.
    Badshah A; Janjua M; Younas F; Halabi AR; Cotant JF
    Am J Med Sci; 2009 Aug; 338(2):164-6. PubMed ID: 19680025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of beat-to-beat electrocardiogram analysis to distinguish QT/QTc interval changes caused by moxifloxacin from those caused by vardenafil.
    Fossa AA; Langdon G; Couderc JP; Zhou M; Darpo B; Wilson F; Wallis R; Davis JD
    Clin Pharmacol Ther; 2011 Sep; 90(3):449-54. PubMed ID: 21814193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers.
    Hofmann C; Banken L; Hahn M; Swearingen D; Nagel S; Martin-Facklam M
    Clin Ther; 2012 Oct; 34(10):2061-71. PubMed ID: 22980315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.